Could Ginkgo Bioworks Stock Help You Become a Millionaire?
A big part of the allure of investing in small and mid-cap stocks is their potential to be worth much more in the future. After all, it's a lot more probable that a company that's only worth a few billion dollars will grow its business enough to double in value than it is for a company that's already worth hundreds of billions. But smaller stocks also come with more risk, as they're often unproven and not well-established businesses.
Ginkgo Bioworks (NYSE: DNA) is a mid-cap company that has some promising long-term growth opportunities. The cell programming specialist can help provide businesses with bioengineered products that can help them become more efficient and provide next-gen products. Uses for its technology include helping healthcare companies develop new drugs, and helping agricultural companies develop crops that are more resistant to disease.
The caveat, however, is that it may take a while before Ginkgo may realize its potential, assuming it does at all. Could investing in this healthcare stock help get your portfolio to $1 million?
Source Fool.com
